Cumbo Alexander
SEC-identified person · CIK 1685994 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Vor Biopharma Inc. VOR | Director | filed 2025–2026 |
| Eliem Therapeutics, Inc. ELYM | Director | filed 2025–2026 |
| Solid Biosciences, LLC SLDB | Director · President and CEO | filed 2022–2026 |
| Verve Therapeutics, Inc. VERV | Director | filed 2022–2025 |
| Ra Pharmaceuticals, Inc. RARX | Director | filed 2018–2020 |
| Sarepta Therapeutics, Inc. SRPT | VP, Head of Commercial | filed 2016–2020 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.